| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 45 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 43 |
| 2 | TACROLIMUS OINTMENT 0.1% | 43 |
| 3 | MYCOPHENOLATE MOFETIL | 31 |
| 4 | PREDNISONE | 19 |
| 5 | MYCOPHENILIC ACID | 13 |
| 6 | MYCOPHENOLIC ACID | 13 |
| 7 | PREDNISOLONE | 12 |
| 8 | PREDNISOLONE ORAL | 12 |
| 9 | PREDNISOLONE ORAL SOLUTION | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 3 | 0.0086 |
| 1 | DACTINOMYCIN | 4 | 0.0018 |
| 2 | FECAL MICROBIOTA SPORES, LIVE-BRPK | 1 | 0.0008 |
| 3 | MYCOPHENILIC ACID | 13 | 0.0006 |
| 4 | BENDAMUSTINE HCL | 8 | 0.0005 |
| 5 | SILVER SULFADIAZINE | 1 | 0.0004 |
| 6 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 7 | MYCOPHENOLIC ACID | 13 | 0.0004 |
| 8 | TREOSULFAN | 1 | 0.0004 |
| 9 | TACROLIMUS OINTMENT 0.1% | 43 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 43 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 13 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 10 |
| 3 | Platinum-based Drug [EPC] | 9 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 8 |
| 5 | Alkylating Drug [EPC] | 6 |
| 6 | Kinase Inhibitor [EPC] | 6 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 5 |
| 8 | Actinomycin [EPC] | 4 |
| 9 | Osmotic Laxative [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 4 | 0.0018 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 13 | 0.0006 |
| 2 | Antiprotozoal [EPC] | 3 | 0.0003 |
| 3 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 4 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 7 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 9 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |